1 mg tirzepatide microdose Microdosing Program Microdosing Tirzepatide Chart: A Weekly

P = 0.007 for superiority) in T2DM patients with a history of cardiovascular disease or current kidney disease in a recently completed trial (AMPLITUDE-O) [63]

Accordingly, supplementing OEA to obese mice reverses this state of dorsal striatal dopamine deficit in a vagal-afferentdependent manner [104]

While they may not be as effective as GLP-1s, they can still support weight management efforts

NICE guidelines (NG136, NG28) recommend individualised blood pressure targets, typically below 140/90 mmHg for most people with diabetes, or below 130/80 mmHg if you have kidney, eye, or cerebrovascular disease

Insomnia is when you have difficulty getting to sleep or can't stay asleep long enough to feel refreshed